COMPANY
Tunitas Therapeutics, Inc.
Timeline
- Trial start Phase 1: Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT02559258 | Escalating Single Dose Study of Epsi- Gam in Healthy Normal Subjects | Phase 1 | Terminated | 2015-08 | 2016-05 (actual) |
NIH awards 12
- NIH award 5R44AI092914-05 FY2015: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A Human Fc Bifunctional Fusion Pro source ↗
- NIH award 5R44AI088950-04 FY2014: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A therapeutic Fc gamma Fel d1 chim source ↗
- NIH award 5R44AI092914-04 FY2014: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A Human Fc Bifunctional Fusion Pro source ↗
- NIH award 5R44AI088950-03 FY2013: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A therapeutic Fc gamma Fel d1 chim source ↗
- NIH award 5R42AI085987-03 FY2013: $831,128 awarded for that fiscal year; activity R42 (STTR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. Therapeutic peanut allergen Fc gamma source ↗
- NIH award 2R44AI092914-03 FY2013: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A Human Fc Bifunctional Fusion Pro source ↗
- NIH award 2R44AI088950-02 FY2012: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A therapeutic Fc gamma Fel d1 chim source ↗
- NIH award 5R43AI092914-02 FY2012: $143,494 awarded for that fiscal year; activity R43 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A Human Fc Bifunctional Fusion Prote source ↗
- NIH award 2R42AI085987-02 FY2012: $868,840 awarded for that fiscal year; activity R42 (STTR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. Therapeutic peanut allergen Fc gamma source ↗
- NIH award 1R43AI092914-01 FY2011: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. A Human Fc Bifunctional Fusion Prote source ↗
- NIH award 1R41AI085987-01 FY2010: $172,386 awarded for that fiscal year; activity R41 (STTR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. Allergen???Fc-gamma1 proteins to tre source ↗
- NIH award 1R43AI088950-01 FY2010: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI SIGAL, NOLAN; recipient as written: TUNITAS THERAPEUTICS, INC., SAN FRANCISCO, CA. Cat allergen-human Fc-gamma1 chimeri source ↗